Vimarsana
Biggest News Aggregation in the World

Page 3 - Yates Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yates Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yates Network Today - Breaking & Trending Today

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Published: September 13, 2022

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company, Lyra or Lyra Therapeutics), a clinical-stage therapeutics company leveraging its...

Source: prnewswire.com
Related Topics:
Kathryn MorrisEllen CavaleriWhile The CompanyYates NetworkExchange CommissionPrnewswire Lyra Therapeutics IncLyra Therapeutics IncCompany Quarterly Report On FormLyra TherapeuticsAward PlanSenior Vice PresidentInvestor RelationsNasdaq Listing RulePrivate Securities Litigation Reform ActQuarterly Report
Concert Pharmaceuticals, Inc.: Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress - Vimarsana News

Concert Pharmaceuticals, Inc.: Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress

Published: September 10, 2022

35 Percent of Patients Treated With CTP-543 12 mg Twice-Daily Achieved At Least 90 Percent Scalp Hair Coverage (SALT Score 10) After 24 Weeks of Treatment Newly-Reported Results Show Significant

Source: finanznachrichten.de
Related Topics:
United StatesKathryn MorrisJustine KoenigsbergBrett KingEuropean Academy Of DermatologyConcert PharmaceuticalsCongress Late Breaking News SessionYates NetworkExchange CommissionYale University School Of MedicineConcert Pharmaceuticals IncDepartment Of DermatologyPatients Treated WithTwice Daily Achieved At LeastScalp Hair CoverageReported Results Show Significant ImprovementEyelash RegrowthPatients Treated With Both DosesYale University SchoolEuropean AcademyCongress Late Breaking NewsAlopecia ToolFast TrackForward LookingNew Drug Application
Lyra Therapeutics to Present at the H.C. Wainwright AnnualGlobal Investment Conference 2022 - Vimarsana News

Lyra Therapeutics to Present at the H.C. Wainwright AnnualGlobal Investment Conference 2022

Published: September 6, 2022

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company or Lyra), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform...

Source: prnewswire.com
Related Topics:
Kathryn MorrisMaria PalasisSecurities Exchange CommissionLotte New York Palace HotelWhile The CompanyYates NetworkCompany Or LyraPrnewswire Lyra Therapeutics IncLyra Therapeutics IncCompany Quarterly Report On FormAnnual Global Investment ConferenceChief Executive OfficerInvestor RelationsPrivate Securities Litigation Reform ActQuarterly ReportLyra TherapeuticsHealth Care Amp Hospitals Medical Pharmaceuticals Biotechnology
Lyra Therapeutics to Present Additional LANTERN Phase 2 Study Results for LYR‑210 in Two Oral Presentations at ARS Annual Meeting - Vimarsana News

Lyra Therapeutics to Present Additional LANTERN Phase 2 Study Results for LYR‑210 in Two Oral Presentations at ARS Annual Meeting

Published: August 29, 2022

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...

Source: prnewswire.com
Related Topics:
United StatesKathryn MorrisMeeting Of The American Rhinologic SocietyHealth DisparitiesYates NetworkUniversity Of North Carolina School MedicineLyra Therapeutics IncLyra TherapeuticsAnnual MeetingAmerican Rhinologic SocietyPresentation DetailsNorth Carolina SchoolChronic Rhinosinusitis HistologyDisease BurdenChronic RhinosinusitisPrivate Securities Litigation Reform ActQuarterly ReportHealth Care Amp Hospitals Medical Pharmaceuticals Biotechnology Clinical Trials Amp Medical Discoveries
Lyra Therapeutics to Present at the William Blair Biotech Focus Conference 2022 - Vimarsana News

Lyra Therapeutics to Present at the William Blair Biotech Focus Conference 2022

Published: July 5, 2022

/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...

Source: prnewswire.com
Related Topics:
Kathryn MorrisMaria PalasisYates NetworkPrnewswire Lyra Therapeutics IncLyra Therapeutics IncWilliam Blair Biotech Focus ConferenceChief Executive OfficerRegis New YorkInvestor RelationsPrivate Securities Litigation Reform ActQuarterly ReportLyra Therapeutics